ANAB   $37.52  2.60% Market Closed After Close 37.53 0.03%

AnaptysBio Inc
Total Cash 350.80M
totalCashPerShare 12.78
EBITDA -154.41M
Total Debt 378.93M
quickRatio 8.902
currentRatio 9.088
Total Revenue 30.47M
debtToEquity 3835.682
Revenue/Share 1.136
ROA -0.20521
ROE -2.14888
grossProfits
freeCashflow -86.93M
operatingCashflow -129.40M
earningsGrowth
revenueGrowth 2.171
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -3.67523
profitMargins 0.0
enterpriseValue 1.14B
forwardPE -5.91349
floatShares 17.91M
sharesOutstanding 30.20M
sharesShort 5.63M
sharesShortPriorMonth 5.66M
dateShortInterest
sharesPercentSharesOut 0.19%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.00%
Short Ratio help_outline 15.33%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 0.36
Price To Book help_outline 112.03
earningsQuarterlyGrowth
netIncomeToCommon -170.12M
trailingEps -6.35%
forwardEps -6.82%
enterpriseToEbitda -7.35
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.7 3Q 2024
institutionsCount 188
lastUpdated Sept. 16, 2024, 3:11 p.m.